Sais e Derivados de API
Os sais dos Ingredientes Farmacêuticos Ativos (API) são compostos formados pela reação de um ácido com uma base, resultando em um equilíbrio iônico. Esses sais frequentemente melhoram a solubilidade e a estabilidade dos APIs, facilitando sua absorção no organismo. Os derivados de API são variantes químicas de um princípio ativo que podem apresentar propriedades aprimoradas ou modificadas para otimizar a eficácia terapêutica. Os sais de APIs são utilizados na formulação de medicamentos orais, injetáveis e tópicos. Além disso, os derivados de API podem melhorar a farmacocinética dos fármacos, permitindo, por exemplo, a liberação controlada de substâncias ativas.
Na CymitQuimica, oferecemos sais e derivados de APIs com a pureza e qualidade necessárias para pesquisa e desenvolvimento de formulações farmacêuticas.
Foram encontrados 79473 produtos de "Sais e Derivados de API"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Capecitabine Related Compound C (2',3'-O-carbonyl-5'-deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H20FN3O7Cor e Forma:White PowderPeso molecular:385.12853Mirtazapine Related Compound A (1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine)
CAS:Compounds containing a pyrimidine ring (whether or notFórmula:C16H17N3Cor e Forma:White Off-White Crystalline PowderPeso molecular:251.14225Dicyclomine Related Compound A ([1,1'-Bi(cyclohexane)]-1-carboxylic acid)
CAS:Cyclanic, cyclenic or cycloterpenic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivativesFórmula:C13H22O2Cor e Forma:White Crystalline PowderPeso molecular:210.16198Rivaroxaban R-enantiomer ((R)-5-Chloro-N-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H18ClN3O5SCor e Forma:Yellow White SolidPeso molecular:435.06557Oxindole
CAS:Lactams, nesoiFórmula:C8H7NOCor e Forma:White Crystalline PowderPeso molecular:133.05276Tetraxetan Related Compound A (2,2',2""-[10-(2-Ethoxy-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetic acid)
CAS:Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFórmula:C18H32N4O8Cor e Forma:Off-White PowderPeso molecular:432.22201Hexyl Methanesulfonate
CAS:Hydrocarbon derivatives containing only sulfo groups, their salts andestersFórmula:C7H16O3SCor e Forma:Clear Yellow LiquidPeso molecular:180.08202Benzyl Chloride ((Chloromethyl)benzene)
CAS:Halogenated derivatives of aromatic hydrocarbons, nesoiFórmula:C7H7ClCor e Forma:Clear Colorless LiquidPeso molecular:126.02363Abacavir Stereoisomers Mixture
Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureCor e Forma:White Off-White PowderTiotropium Related Compound H ((2RS,3aSR,5RS,6RS,6aRS)-6-Hydroxy-4,4-dimethylhexahydro-2H-2,5-methanofuro[3,2-b]pyrrol-4-ium bromide)
Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFórmula:C9H16BrNO2Cor e Forma:White PowderPeso molecular:250.14Gadodiamide Related Compound B (Gadolinium disodium diethylenetriamine pentaacetic acid)
CAS:Compounds, inorganic or organic, of rare-earth metals, of yttrium or of scandium, or of mixtures of these metals, excluding cerium compounds, nesoiFórmula:C14H18GdN3Na2O10Cor e Forma:White PowderPeso molecular:591.54Lamotrigine Related Compound D (N-[5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide)
CAS:Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFórmula:C16H9Cl4N5OCor e Forma:White PowderPeso molecular:426.95612Glycopyrrolate Related Compound B (1-Methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate Hydrochloride)
CAS:Aromatic polycarboxylic acids, their anhydrides, halideFórmula:C18H25NO3Cor e Forma:Off-White PowderPeso molecular:303.18344Terazosin Related Compound C (1,4-Bis(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine, dihydrochloride)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C24H28N8O4·2HClCor e Forma:Off-White PowderPeso molecular:492.22335Milnacipran Related Compound C ((1RS ,2SR)-2-[(1,3-Dioxoisoindolin-2-yl)methyl]-N,N-diethyl-1-phenylcyclopropane-1-carboxamide)
CAS:Imides and their derivatives (excluding sacharin), salt thereofFórmula:C23H24N2O3Cor e Forma:SolidPeso molecular:376.17869Vinorelbine Related Compound A (4-O-Deacetylvinorelbine tartrate)
CAS:Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFórmula:C43H52N4O7·2C4H6O6Cor e Forma:Light Yellow Off-White PowderPeso molecular:736.3836Moexipril Related Compound G ((S)-6,7-dimethoxy-2-{(S)-2-[(S)-1-methoxy-1-oxo-4-phenylbutan-2-ylamino]propanoyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, hydrochloride)
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFórmula:C26H32N2O7·HClCor e Forma:White Off-White Light Pink PowderPeso molecular:484.22095Diphenhydramine Related Compound A (2-(Diphenylmethoxy)-N-methylethanamine hydrochloride)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C16H19NO·HClCor e Forma:White Crystalline PowderPeso molecular:277.79Nicotine Related Compound G ((S)-3-(piperidin-2-yl)pyridine)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFórmula:C10H14N2Cor e Forma:Clear Colorless Pale Yellow Oily LiquidPeso molecular:162.1157Linezolid Related Compound B ((S)-N-{[3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl]methyl}thioacetamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H20FN3O3SCor e Forma:White SolidPeso molecular:353.12094Dextroamphetamine Related Compound A (1-Phenyl-2-propanol)
CAS:Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiFórmula:C9H12OCor e Forma:Colorless LiquidPeso molecular:136.08882Potassium Ferricyanide
CAS:Complex cyanidesFórmula:K3Fe(CN)6Cor e Forma:Dark Red Crystalline PowderPeso molecular:328.8445Doxazosin Related Compound C (2-chloro-4-amino-6,7-dimethoxyquinazoline)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C10H10ClN3O2Cor e Forma:White PowderPeso molecular:239.66Timolol Related Compound C (N-(tert-Butyl)-2,3-bis(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-1-amine maleate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H31N7O4S2·C4H4O4Cor e Forma:White Off-White PowderPeso molecular:601.19885Fluoxetine Related Compound A (N-Methyl-3-phenyl-3-[3-(trifluoromethyl)phenoxy]propan-1-amine hydrochloride)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C17H18F3NO·HClCor e Forma:White Yellow Fine PowderPeso molecular:309.13405Phthalazine
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C8H6N2Cor e Forma:Light Yellow PowderPeso molecular:130.0531Enanthic Acid (Heptanoic Acid)
CAS:Saturated acyclic monocarboxylic acids and their anhydrides, halides, peroxides etc, nesoiFórmula:C7H14O2Cor e Forma:Colorless LiquidPeso molecular:130.19 g/molAmifostine Disulfide (1,3-Propanediamine, N,N-(dithiodi-2,1-ethanediyl)bis, tetrahydrochloride)
CAS:Organo-sulfur compounds, nesoiFórmula:C10H30N4S2Cl4Cor e Forma:White PowderPeso molecular:410.0666Telmisartan Related Compound B (4'-[(1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl]biphenyl-2-carboxylic acid)
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C33H30N4O2Cor e Forma:White PowderPeso molecular:514.62Moxifloxacin Related Compound B (1-Cyclopropyl-6,8-dimethoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate)
Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ringFórmula:C22H27N3O5·HCl·H2OCor e Forma:SolidPeso molecular:413.195072,4-Dichlorophenol
CAS:Derivatives of phenols or phenol-alcohols, containing only halogen substitutes and their salts, nesoiFórmula:C6H4Cl2OCor e Forma:White Crystalline PowderPeso molecular:161.96392Carbinoxamine Related Compound B ((4-Chlorophenyl)(pyridin-2-yl)methanol)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C12H10ClNOCor e Forma:Off-White SolidPeso molecular:219.04509Frovatriptan Related Compound A ((R)-3-Amino-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C13H15N3OCor e Forma:Off-White SolidPeso molecular:229.12Amrinone Related Compound C (6-Oxo-1,6-dihydro-[3,4'-bipyridine]-5-carbonitrile)
CAS:Lactams, nesoiFórmula:C11H7N3OCor e Forma:Tan Off-White PowderPeso molecular:197.05891Pyrazinamide Related Compound B (Pyrazinecarbonitrile)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C5H3N3Cor e Forma:White PowderPeso molecular:105.0327Flavoxate Related Compound A (3-Methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylic acid)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C17H12O4Cor e Forma:White Off-White PowderPeso molecular:280.07356Zolmitriptan Related Compound H (4,4-Diethoxy-N,N-dimethylbutan-1-amine)
CAS:Non-aromatic amino-compounds with oxygen functionFórmula:C10H23NO2Cor e Forma:Clear Colorless LiquidPeso molecular:189.17288Spironolactone Related Compound B ((2'R)-7α-(Acetylthio)-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione)
CAS:Lactones, nesoiFórmula:C24H30O4SCor e Forma:Off-White SolidPeso molecular:414.18648Tranylcypromine Related Compound B ((E)-3-Phenylallylamine hydrochloride)
CAS:Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFórmula:C9H11N·HClCor e Forma:White PowderPeso molecular:169.66Piroctone Related Compound B (4-methyl-6-(2,4,4-trimethylpentyl)-2H-pyran-2-one)
CAS:Heterocyclic compounds with oxygen hetero-atom(s) onlyFórmula:C14H22O2Cor e Forma:Colorless LiquidPeso molecular:222.16198Fexofenadine Related Compound C (4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]-1-(4-isopropylphenyl)butan-1-ol hydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C31H39NO2·HClCor e Forma:White PowderPeso molecular:494.12Nitazoxanide Related Compound B (2-Hydroxy-N-(5-nitrothiazol-2-yl) benzamide)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C10H7N3O4SCor e Forma:Pale Yellow PowderPeso molecular:265.01573Midodrine Related Compound A (1-(2,5 Dimethoxyphenyl)-2-aminoethanol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C10H15NO3Cor e Forma:White Off-White Light Yellow PowderPeso molecular:197.10519Rivastigmine Related Compound C ((S)-3-[1-(Dimethylamino)ethyl]phenol)
CAS:Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof, nesoiFórmula:C10H15NOCor e Forma:White PowderPeso molecular:165.11536Fosamprenavir Related Compound A (Calcium (6R,7S,16S,17R)-4,19-bis[(4-aminophenyl)sulfonyl]-7,16-dibenzyl-2,21-dimethyl-9,14-dioxo-10,13-dioxa-4,8,15,19-tetraazadocosane-6,17-diyl bis(phosphate))
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Fórmula:C44H58CaxN6O16P2S2Cor e Forma:White Off-White PowderPeso molecular:1132.20778Desloratadine Related Compound F (8-Chloro-6,11-dihydro-11-(N-formyl-4-piperidinylidene) -5H-benzo[5,6]cyclohepta[1,2-b]pyridine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C20H19ClN2OCor e Forma:White SolidPeso molecular:338.11859Deferasirox
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C21H15N3O4Cor e Forma:White PowderPeso molecular:373.10626Temazepam Related Compound A (5-chloro-2-methylaminobenzophenone)
CAS:Heterocyclic compounds (excluding aromatic or modifiedFórmula:C14H12ClNOCor e Forma:PowderPeso molecular:245.06074Clopidogrel Diester Analog (R)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate, sulfate
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C24H21Cl2NO4S·H2SO4Cor e Forma:White Off-White SolidPeso molecular:587.02421Repaglinide Related Compound E ((R)-2-Ethoxy-4-[2-({3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C27H36N2O4Cor e Forma:PowderPeso molecular:452.26751Aztreonam E-Isomer
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C13H17N5O8S2Cor e Forma:PowderPeso molecular:435.05185Atenolol Related Compound E (2,2'-{[(2-Hydroxypropane-1,3-diyl)bis(oxy)]bis(4,1-phenylene)}diacetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C19H22N2O5Cor e Forma:White SolidPeso molecular:358.15287Argatroban Related Compound C ((2R,4R)-1-[N^8-amino- N^2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
Sulfonamides, excluding drugsFórmula:C23H37N7O5SCor e Forma:Off-White PowderPeso molecular:523.25769Betamethasone Dipropionate Related Compound H (6α-Bromo-9-fluoro-11β-hydroxy-16β-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropionate)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFórmula:C28H36BrFO7Cor e Forma:White PowderPeso molecular:582.162842-Oxo R-Clopidogrel (methyl (2R)-2-(2-chlorophenyl)-2-(2-oxo-2,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5(4H)-yl)acetate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H16ClNO3SCor e Forma:White Off-White SolidPeso molecular:337.05394Pramipexole Related Compound D ((R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride)
CAS:Compounds containing a benzothiazole ring-system (whethFórmula:C10H17N3S·2HClCor e Forma:Off-White PowderPeso molecular:283.06767Articaine Related Compound A (Methyl 4-methyl-3-[2-(propylamino)acetamido]thiophene-2-carboxylate hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C12H18N2O3S·HClCor e Forma:Off-White White PowderPeso molecular:270.10381Ranolazine Related Compound D (2,2'-(Piperazine-1,4-diyl)bis[N-(2,6-dimethylphenyl)acetamide])
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C24H32N4O2Cor e Forma:White Off-White PowderPeso molecular:408.25253Clopidogrel N-Oxide (5-((S)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H16ClNO3SCor e Forma:Pale Yellow SolidPeso molecular:337.05394Didanosine Related Compound B (2',3'-dideoxyadenosine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C10H13N5O2Cor e Forma:Beige PowderPeso molecular:235.10692Methylene Simvastatin ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbut-3-enoate)
CAS:Lactones nesoiFórmula:C25H36O5Cor e Forma:White PowderPeso molecular:416.25627Acetaminophen Related Compound J (N-(4-chlorophenyl)acetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C8H8ClNOCor e Forma:White Light Yellow Brown Crystalline PowderPeso molecular:169.61 g/molZidovudine Related Compound D ([1-(2-Deoxy-β-D-ribofuranosyl)]thymine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C10H14N2O5Cor e Forma:White Crystalline PowderPeso molecular:242.09027Desfluoro Aprepitant (5-{[(2R,3S)-2-{(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-phenylmorpholino]methyl}-2H-1,2,4-triazol-3(4H)-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C23H22F9N4O3Cor e Forma:White SolidPeso molecular:573.15482Phenylbutyrate Related Compound B (3,4-dihydronaphthalen-1(2H)-one)
CAS:Aromatic ketones without other oxygen function, nesoiFórmula:C10H10OCor e Forma:Yellow LiquidPeso molecular:146.19Prednicarbate Related Compound C (prednisolone-21-propionate)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C24H3206Cor e Forma:PowderPeso molecular:3519.08705Clopidogrel Open Ring Methyl Ester Hydrochloride (methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C15H16ClNO2SHClCor e Forma:White Off-White SolidPeso molecular:346.28Amoxapine Related Compound G (3-Chloro-11-(piperazin-1-yl)dibenzo[b,f][1,4]oxazepine)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C17H16ClN3OCor e Forma:Yellow PowderPeso molecular:313.09819Carglumic Acid Related Compound C ((S)-2-[(S)-4-Carboxy-2-ureidobutanamido]pentanedioic acid)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFórmula:C11H17N3O8Cor e Forma:Off-White PowderPeso molecular:319.10156Rivaroxaban Open Oxomorpholine Ring ((S)-5-chloro-N-((3-(4-(2-hydroxy-N-(2-hydroxyethyl)acetamido) phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H20ClN3O6SCor e Forma:White Off-White SolidPeso molecular:453.07613Sulfamethoxazole Related Compound F (4-amino-N-(3-methylisoxazol-5-yl)benzenesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C10H11N3O3SCor e Forma:Off-White Yellow Fine PowderPeso molecular:253.28Clopidogrel Piperidinylidene Analog ((E)-2-(1-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4-((2-(3-methoxyphenyl)-2-oxoethyl)thio)piperidin-3-ylidene)acetic acid)
Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C25H26ClNO6SCor e Forma:Pale Yellow SolidPeso molecular:503.11694Cilostazol Related Compound A (6-hydroxy-3,4-dihydro-1H-quinolin-2-one)
CAS:Lactams not elsewhere specified or includedFórmula:C9H9NO2Cor e Forma:Yellow White PowderPeso molecular:163.06333Propofol Related Compound B (2,6-Diisopropyl-1,4-benzoquinone)
CAS:Other quinonesFórmula:C12H16O2Cor e Forma:Yellow LiquidPeso molecular:192.11503Ursodiol Related Compound H (3β, 7β-Dihydroxy-5β-cholan-24-oic acid)
CAS:Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFórmula:C24H40O4Cor e Forma:White Fine PowderPeso molecular:392.29266Ranolazine Related Compound C (N-(2,6-Dimethylphenyl)-2-(piperazin-1-yl)acetamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C14H21N3OCor e Forma:White PowderPeso molecular:247.16846Epoprostenol Related Compound A (7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxyoct-1-enyl]cyclopentyl}-6-oxoheptanoic acid)
CAS:Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFórmula:C20H34O6Cor e Forma:White PowderPeso molecular:370.48Azathioprine Related Compound A (1-Methyl-4-nitro-1H-imidazol-5-amine)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C4H6N4O2Cor e Forma:Yellow PowderPeso molecular:142.12Fosinopril Related Compound G ((4-phenylbutyl)phosphinyl acetic acid, disodium salt)
CAS:Organo-inorganic compounds, nesoiFórmula:C12H15Na2O4PCor e Forma:Off-White PowderPeso molecular:300.05033Fentanyl Related Compound A ((2-bromoethyl)benzene)
CAS:Halogenated derivatives of aromatic hydrocarbons not elFórmula:C8H9BrCor e Forma:LiquidPeso molecular:185.07 g/molProstaglandin A1
CAS:Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFórmula:C20H32O4Cor e Forma:White PowderPeso molecular:336.23006Cefuroxime Axetil δ-3-Isomers ((1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C20H22N4O10SCor e Forma:Tan PowderPeso molecular:510.10566Particle Count Set (2 blanks (28 mL each) and 2 suspensions (25 mL each))
Polystyrene,nesoiCor e Forma:Clear Milky Liquid SuspensionDoxapram Related Compound B (1-Ethyl-4-{2-[(2-hydroxyethyl)amino]ethyl}-3,3-diphenylpyrrolidin-2-one hydrochloride)
CAS:Lactams, nesoiFórmula:C22H29CIN2O2Cor e Forma:White Off-White PowderPeso molecular:492.12738Almotriptan Related Compound B (2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine hemifumarate)
CAS:Aromatic or modified aromatic drugs with nitrogen heteroFórmula:C15H21N3O2S·C4H4O4Cor e Forma:PowderPeso molecular:307.13545Pitavastatin Related Compound B ((4R,6S)-6-{(E)-2-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]vinyl}-4-hydroxytetrahydro-2H-pyran-2-one)
CAS:Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFórmula:C25H22FNO3Cor e Forma:Off-White PowderPeso molecular:403.15837Piroctone Related Compound A ((2-[5-methyl-3-(2,4,4-trimethylpentyl)-4,5-dihydroisoxazol-5-yl]acetic acid) 2-aminoethanol salt)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H32N2O4Cor e Forma:Brown LiquidPeso molecular:316.44Valacyclovir Related Compound E (2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-benzyloxycarbonyl-L-valinate)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C21H26N6O6Cor e Forma:White Crystalline PowderPeso molecular:458.47Fenoldopam Related Compound A (N-Methyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol hydrochloride)
Aromatic or modified aromatic drugs with nitrogen heterFórmula:C17H18ClNO3·HClCor e Forma:PowderPeso molecular:356.24Sulfasalazine Related Compound K (5-{4-[N-(6-Methylpyridin-2-yl)sulfamoyl]phenyldiazenyl}salicylic acid)
CAS:Sulfonamides, nesoiFórmula:C19H16N4O5SCor e Forma:Yellow PowderPeso molecular:412.42N-Nitroso Diclofenac (2-(2-((2,6-dichlorophenyl) (nitroso)amino)phenyl)acetic acid)
CAS:Compounds with other nitrogen function, nesoiFórmula:C14H10Cl2N2O3Cor e Forma:Off-White PowderPeso molecular:324.00685Gadoteridol Related Compound C (1,4,7,10-Tetraaza-11-oxo-bicyclo[8.2.2]tetradecane-4,7-diacetic acid)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFórmula:C14H24N4O5Cor e Forma:White Light Yellow PowderPeso molecular:328.17467Dorzolamide Related Compound B ((4RS,6SR)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride)
CAS:Sulfonamides, nesoiFórmula:C10H16N2O4S3·HClCor e Forma:White SolidPeso molecular:324.02722Baclofen Related Compound A (4-(4-Chlorophenyl)-2-pyrrolidinone)
CAS:Lactams, nesoiFórmula:C10H10ClNOCor e Forma:White CrystalsPeso molecular:195.04509Etidronate Disodium Related Compound A (Sodium phosphite dibasic pentahydrate)
CAS:Phosphinates (hypophosphites) and phosphonates (phosphiFórmula:Na2HPO3·5H20Cor e Forma:White Waxy SolidPeso molecular:125.94587Sevoflurane Related Compound A (1,1,1,3,3-Pentafluoroisopropenyl fluoromethyl ether)
CAS:Ethers of monohydric alcohols, nesoiFórmula:C4H2F6OCor e Forma:Colorless Clear LiquidPeso molecular:180.00098Cinacalcet Related Compound D ((S)-N-[1-(Naphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride)
CAS:Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFórmula:C22H22F3N·HClCor e Forma:Pale Yellow PowderPeso molecular:393.14711Dorzolamide Hydrochloride Related Compound A ((4R,6R)-4-(ethylamino)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide, monohydrochloride)
CAS:Sulfonamides, nesoiFórmula:C10H16N2O4S3·HClCor e Forma:White PowderPeso molecular:324.02722Diethyltoluamide Related Compound A (N,N-Diethyl-4-toluamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C12H17NOCor e Forma:White CrystalsPeso molecular:191.13101Linezolid Related Compound A ((R)-5-(azidomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C14H16FN5O3Cor e Forma:White PowderPeso molecular:321.12372
![Lamotrigine Related Compound D (N-[5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichloro…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1356790.webp&w=3840&q=75)
![Milnacipran Related Compound C ((1RS ,2SR)-2-[(1,3-Dioxoisoindolin-2-yl)methyl]-N,N-diethyl-1-phen…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1443680.webp&w=3840&q=75)
![Repaglinide Related Compound E ((R)-2-Ethoxy-4-[2-({3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}ami…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1600868.webp&w=3840&q=75)
![Desfluoro Aprepitant (5-{[(2R,3S)-2-{(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-phenylmorphol…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1041992.webp&w=3840&q=75)
![Valacyclovir Related Compound E (2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-benzy…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1707872.webp&w=3840&q=75)